Julie Burke
Psychiatric/Mental Health, Adult · Carrollton, GANPI 1366797391
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $68,250 of the $78,148 with a category attached, or 87.3%. AbbVie accounts for 94.0% of it on its own, with 21 other manufacturers making up the rest. 2025 is the largest year on record at $64,714, more than ten times the $1,360 reported in 2021. Among psychiatric/mental health, adult clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 526 payments — averaging $148.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$73K
- Otsuka America Pharmaceutical, Inc.$644
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$589
- Supernus Pharmaceuticals, Inc.$387
- Axsome Therapeutics, Inc.$358
- Vanda Pharmaceuticals Inc.$348
- plus $2K from 16 others
What the payments were for
- Speaking & faculty fees$68,25087%
- Travel & lodging$3,0084%
- Food & beverage$6,6929%
- Education$1990%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 261 | $73,443 |
| Otsuka America Pharmaceutical, Inc. | 38 | $644 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 44 | $589 |
| Supernus Pharmaceuticals, Inc. | 23 | $387 |
| Axsome Therapeutics, Inc. | 15 | $358 |
| Vanda Pharmaceuticals Inc. | 19 | $348 |
| Teva Pharmaceuticals USA, Inc. | 13 | $313 |
| Avanir Pharmaceuticals, Inc. | 22 | $312 |
| Neurocrine Biosciences, Inc. | 15 | $306 |
| Sunovion Pharmaceuticals Inc. | 15 | $292 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $259 |
| Lundbeck LLC | 11 | $199 |
| Johnson & Johnson | 9 | $196 |
| Alkermes, Inc. | 9 | $168 |
| Corium, LLC | 4 | $89 |
| Alfasigma USA, Inc. | 4 | $78 |
| Idorsia Pharmaceuticals US Inc | 4 | $76 |
| Biogen | 1 | $27 |
| Luye Pharma (USA) Ltd. | 1 | $24 |
| Tempus AI, Inc | 1 | $14 |
| Bausch Health US, LLC | 1 | $13 |
| Eisai Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$68,605
How this compares
$78,148 in reported general payments places this provider in the 95th percentile of 22 psychiatric/mental health, adult providers in Georgia.
See all psychiatric/mental health, adult providers in Georgia →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 22 | $178,867 |
| VraylarCariprazine Hcl | 14 | $21,104 |
| Hydroxyzine Pamoate | 16 | $979 |
| Lurasidone Hcl | 12 | $871 |
| Vilazodone Hcl | 13 | $660 |
| Clonazepam | 35 | $644 |
| Prazosin Hcl | 19 | $533 |
| Buspirone Hcl | 47 | $447 |
| Venlafaxine Hcl | 24 | $426 |
| Lamotrigine | 46 | $406 |
| Quetiapine Fumarate | 25 | $375 |
| Olanzapine | 17 | $234 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 14 | $200 |
| Clomipramine Hcl | 12 | $198 |
| Sertraline Hcl | 24 | $149 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo | $313 | $178,86722 claims |
| AbbVieVraylar | $73,443 | $21,10414 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 22 psychiatric/mental health, adult providers in Georgia.
Other psychiatric/mental health, adult in Carrollton
- Vernell FloodNorcross$3K
- Dene BellamyDecatur$1K
- Jennifer SimondsAugusta$1K
- Wendy Barnes-MellstromSmyrna$800
- Joann KaragaAtlanta$691
- Barbara HartsfieldAtlanta$588
- Jackie WilliamsAtlanta$346
- Pamela RatajczakMilledgeville$247
- Ailaf DarfoorLawrenceville$213
- Carmen TurnerMoultrie$206
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.